Cargando…
Development of Gene Therapy Using Prostate‐specific Membrane Antigen Promoter/Enhancer with Cre Recombinase/LoxP System for Prostate Cancer Cells under Androgen Ablation Condition
To enhance the efficacy of suicide gene therapy for prostate cancer under androgen deprivation, we designed a promoter system that consists of the prostate‐specific membrane antigen (PSMA) promoter/enhancer (PEPM) and Cre‐loxP DNA recombination system. We constructed two kinds of plasmids. One plasm...
Autores principales: | Ikegami, Shusei, Tadakuma, Takushi, Suzuki, Satoshi, Yoshimura, Ichiro, Asano, Tomohiko, Hayakawa, Masamichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926883/ https://www.ncbi.nlm.nih.gov/pubmed/12417046 http://dx.doi.org/10.1111/j.1349-7006.2002.tb01218.x |
Ejemplares similares
-
Dermal Delivery of Constructs Encoding Cre Recombinase to Induce Skin Tumors in Pten(LoxP/LoxP);Braf(CA/+) Mice
por: Deken, Marcel A., et al.
Publicado: (2016) -
Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre mice
por: Kortüm, Benedikt, et al.
Publicado: (2015) -
Construction of Marker-Free Transgenic Strains of Chlamydomonas reinhardtii Using a Cre/loxP-Mediated Recombinase System
por: Kasai, Yuki, et al.
Publicado: (2016) -
Down-regulation of Irf8 by Lyz2-cre/loxP accelerates osteoclast differentiation in vitro
por: Saito, Emi, et al.
Publicado: (2016) -
Myh6-driven Cre recombinase activates the DNA damage response and the cell cycle in the myocardium in the absence of loxP sites
por: Wang, Xinrui, et al.
Publicado: (2020)